Loading clinical trials...
Loading clinical trials...
CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients: a PK Pilot Study
Conditions
Interventions
Cytogam
Locations
1
United States
University of Minnesota
Minneapolis, Minnesota, United States
Start Date
October 2, 2025
Primary Completion Date
August 1, 2027
Completion Date
August 1, 2027
Last Updated
October 31, 2025
NCT06439342
NCT07235683
NCT06958796
NCT06453460
NCT05564598
NCT04702022
Lead Sponsor
University of Minnesota
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions